Mar 18, 2026 09:21AM
Mar 9, 2026 02:47PM
Oct 16, 2025 08:30AM
Oct 16, 2025 08:30AM
Sep 10, 2025 04:01PM
Sep 10, 2025 04:01PM
Jul 29, 2025 06:30AM Compass Pathways adds Justin Gover to board of directors
Jul 29, 2025 06:30AM
Jun 24, 2025 08:31AM
Jun 24, 2025 08:30AM
Feb 11, 2025 04:17AM
Jan 3, 2024 04:14PM
Oct 2, 2023 02:26PM
Nov 7, 2022 08:30AM Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Andrea DiFabio as Chief Legal Officer and Corporate Secretary
Nov 7, 2022 08:30AM
Aug 9, 2022 04:01PM
Aug 9, 2022 04:01PM
Jun 23, 2022 09:24AM
May 10, 2022 04:01PM
May 10, 2022 04:01PM
Mar 1, 2022 04:01PM Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate Update
Mar 1, 2022 04:01PM
Jan 10, 2022 08:34AM
Jan 10, 2022 08:30AM
Jan 10, 2022 08:30AM
Oct 4, 2021 09:25AM
Nov 5, 2020 04:01PM
Nov 5, 2020 04:01PM Xenon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Jul 21, 2020 09:30AM
Sep 9, 2019 04:06PM
Sep 9, 2019 04:01PM
Sep 9, 2019 04:01PM
Sep 11, 2018 06:38AM
Sep 10, 2018 09:17PM
Sep 10, 2018 09:17PM Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program
May 15, 2018 09:20AM
Apr 26, 2017 06:30AM
Mar 24, 2017 09:31AM
Jan 10, 2017 02:00PM
Jul 1, 2015 01:04PM
Jul 1, 2015 08:00AM
Jul 1, 2015 08:00AM Teva and Xenon Provide Update on TV-45070 Phase 2b Study in Osteoarthritis Pain
Apr 2, 2015 08:00AM
Apr 2, 2015 08:00AM
Apr 2, 2015 08:00AM

1,159,115 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All